Toltec Pharmaceuticals Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Toltec Pharmaceuticals General Information

Description

Operator of a biotechnology company intended to develop therapeutics for the treatment of low reproductive tract infection. The company is involved in the development of novel therapeutic assets addressing the unmet healthcare needs of women, enabling medical researchers to offer effective treatments to patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1115 West Wrightwood Avenue
  • Suite 1W
  • Chicago, IL 60014
  • United States
+1 (773)
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1115 West Wrightwood Avenue
  • Suite 1W
  • Chicago, IL 60014
  • United States
+1 (773)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Toltec Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 27-Oct-2023 Completed Out of Business
1. Seed Round 19-Jan-2016 Completed Generating Revenue
To view Toltec Pharmaceuticals’s complete valuation and funding history, request access »

Toltec Pharmaceuticals Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 14

    Granted

  • Pending

  • Expiring in next 12 mo

Toltec Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2853152-A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms Active 30-Nov-2007
ES-2572580-T3 Compositions and methods to treat vaginal infections and pathogenic vaginal biofilms Active 30-Nov-2007
US-8349368-B2 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms Active 30-Nov-2007
ES-2588437-T3 Compositions and methods to treat vaginal infections and pathogenic vaginal biofilms Active 30-Nov-2007
CA-2706709-A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms Active 30-Nov-2007 A61K33/22
To view Toltec Pharmaceuticals’s complete patent history, request access »

Ready to get started?

Request a free trial

Toltec Pharmaceuticals FAQs

  • When was Toltec Pharmaceuticals founded?

    Toltec Pharmaceuticals was founded in 2006.

  • Where is Toltec Pharmaceuticals headquartered?

    Toltec Pharmaceuticals is headquartered in Chicago, IL.

  • What industry is Toltec Pharmaceuticals in?

    Toltec Pharmaceuticals’s primary industry is Biotechnology.

  • Is Toltec Pharmaceuticals a private or public company?

    Toltec Pharmaceuticals is a Private company.

  • What is Toltec Pharmaceuticals’s current revenue?

    The current revenue for Toltec Pharmaceuticals is .

  • How much funding has Toltec Pharmaceuticals raised over time?

    Toltec Pharmaceuticals has raised $4.03M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »